標(biāo)題: Titlebook: Melanoma; Howard L. Kaufman,Janice M. Mehnert Book 2016 Springer International Publishing Switzerland 2016 Diagnosis.Immunotherapy.Melanom [打印本頁] 作者: Hayes 時間: 2025-3-21 17:32
書目名稱Melanoma影響因子(影響力)
書目名稱Melanoma影響因子(影響力)學(xué)科排名
書目名稱Melanoma網(wǎng)絡(luò)公開度
書目名稱Melanoma網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Melanoma被引頻次
書目名稱Melanoma被引頻次學(xué)科排名
書目名稱Melanoma年度引用
書目名稱Melanoma年度引用學(xué)科排名
書目名稱Melanoma讀者反饋
書目名稱Melanoma讀者反饋學(xué)科排名
作者: 新鮮 時間: 2025-3-21 20:28 作者: 惡意 時間: 2025-3-22 02:49
Adjuvant Therapy of Melanoma,2b (HDI) is the main adjuvant therapeutic mainstay in high-risk disease following definitive resection. In this chapter, we review the evidence supporting the use of adjuvant HDI in high-risk melanoma. We also discuss some of the other treatment modalities that have been evaluated including vaccines, chemotherapy, and radiotherapy.作者: perpetual 時間: 2025-3-22 08:32 作者: Pcos971 時間: 2025-3-22 10:52
Pediatric Melanoma and Atypical Melanocytic Neoplasms,anoma and atypical melanocytic neoplasms, including the roles of and unresolved questions surrounding sentinel lymph node biopsy, completion lymphadenectomy, adjuvant therapy, and treatment of advanced disease.作者: Infirm 時間: 2025-3-22 13:38 作者: 魯莽 時間: 2025-3-22 17:13
Checkpoint Blockade for the Treatment of Advanced Melanoma,future directions, including combination strategies. This chapter is focused on melanoma, but the principles related to this immunotherapy approach are applicable to patients with many types of malignancies.作者: Accolade 時間: 2025-3-23 01:07 作者: 夸張 時間: 2025-3-23 02:58 作者: 忘川河 時間: 2025-3-23 05:33 作者: Affirm 時間: 2025-3-23 10:50 作者: Anhydrous 時間: 2025-3-23 16:06 作者: 謙虛的人 時間: 2025-3-23 21:03
Cancer Treatment and Researchhttp://image.papertrans.cn/m/image/630294.jpg作者: esculent 時間: 2025-3-23 22:32
978-3-319-34637-3Springer International Publishing Switzerland 2016作者: Amendment 時間: 2025-3-24 04:43 作者: Ccu106 時間: 2025-3-24 07:52
https://doi.org/10.1007/978-3-319-22539-5Diagnosis; Immunotherapy; Melanoma; Prevention; Treatment作者: Tinea-Capitis 時間: 2025-3-24 11:51
Batool Shannan,Michela Perego,Rajasekharan Somasundaram,Meenhard Herlynwhen using these. Innovation as a concept is constantly being subdivided into increasingly finer distinctions, which, in turn, determine the discourse. The book takes a close look at these, further taking into 978-3-642-43438-9978-3-642-21723-4作者: 華而不實 時間: 2025-3-24 17:15
Sancy A. Leachman,Pamela B. Cassidy,Suephy C. Chen,Clara Curiel,Alan Geller,Daniel Gareau,Giovanni Pwhen using these. Innovation as a concept is constantly being subdivided into increasingly finer distinctions, which, in turn, determine the discourse. The book takes a close look at these, further taking into 978-3-642-43438-9978-3-642-21723-4作者: 注入 時間: 2025-3-24 19:47 作者: 豐滿中國 時間: 2025-3-24 23:12
Diwakar Davar,John M. Kirkwoodwhen using these. Innovation as a concept is constantly being subdivided into increasingly finer distinctions, which, in turn, determine the discourse. The book takes a close look at these, further taking into 978-3-642-43438-9978-3-642-21723-4作者: Locale 時間: 2025-3-25 07:10 作者: 人類學(xué)家 時間: 2025-3-25 10:53 作者: Abominate 時間: 2025-3-25 13:35
Deborah J. L. Wong,Antoni Ribaswhen using these. Innovation as a concept is constantly being subdivided into increasingly finer distinctions, which, in turn, determine the discourse. The book takes a close look at these, further taking into 978-3-642-43438-9978-3-642-21723-4作者: GROSS 時間: 2025-3-25 16:47
Alexander N. Shoushtari,Richard D. Carvajalwhen using these. Innovation as a concept is constantly being subdivided into increasingly finer distinctions, which, in turn, determine the discourse. The book takes a close look at these, further taking into 978-3-642-43438-9978-3-642-21723-4作者: 疲勞 時間: 2025-3-25 23:05
James S. Goydos,Steven L. Shoenwhen using these. Innovation as a concept is constantly being subdivided into increasingly finer distinctions, which, in turn, determine the discourse. The book takes a close look at these, further taking into 978-3-642-43438-9978-3-642-21723-4作者: Flustered 時間: 2025-3-26 02:51 作者: 搖曳 時間: 2025-3-26 05:18 作者: Lament 時間: 2025-3-26 11:39 作者: 殺子女者 時間: 2025-3-26 15:44
Nour Kibbi,Harriet Kluger,Jennifer Nam Choi put forward, giving, by way of examples, a detailed description of concepts we draw upon when using these. Innovation as a concept is constantly being subdivided into increasingly finer distinctions, which, in turn, determine the discourse. The book takes a close look at these, further taking into 作者: 雜色 時間: 2025-3-26 20:40
Vadim P. Koshenkov,Joe Broucek,Howard L. Kaufman put forward, giving, by way of examples, a detailed description of concepts we draw upon when using these. Innovation as a concept is constantly being subdivided into increasingly finer distinctions, which, in turn, determine the discourse. The book takes a close look at these, further taking into 作者: Brain-Waves 時間: 2025-3-26 23:27 作者: Blazon 時間: 2025-3-27 03:20 作者: 人類的發(fā)源 時間: 2025-3-27 07:08
Radhika Sreeraman Kumar,Jane L. Messina,Damon Reed,Fariba Navid,Vernon K. Sondak put forward, giving, by way of examples, a detailed description of concepts we draw upon when using these. Innovation as a concept is constantly being subdivided into increasingly finer distinctions, which, in turn, determine the discourse. The book takes a close look at these, further taking into 作者: GULP 時間: 2025-3-27 11:14
Methods of Melanoma Detection,/or enhance malignant features of individual melanocytic lesions (and algorithms that are available to interpret the results obtained from these devices) will be compared and contrasted. In vivo confocal microscopy and other cellular-level in vivo technologies will be compared to traditional tissue 作者: 無孔 時間: 2025-3-27 16:03
Principles of Melanoma Staging,so changed dramatically over time, impacted by techniques such as lymphatic mapping and sentinel lymph node biopsy (SLNB) and changes in pathological evaluation of the regional lymph nodes. Additionally, stratification of distant metastases has evolved as survival outcomes have been shown to vary ba作者: 引導(dǎo) 時間: 2025-3-27 18:29
Chemotherapy for Melanoma,options exist for first-line management of advanced-stage melanoma, chemotherapy may still be important in the palliative treatment of refractory, progressive, and relapsed melanoma. We review the various chemotherapy options available for use in the treatment and palliation of advanced-stage melano作者: 啟發(fā) 時間: 2025-3-27 23:08 作者: 有惡意 時間: 2025-3-28 05:14
Treatment of Uveal Melanoma,mitogen-activated protein kinase, Akt, and protein kinase C. A recent trial of the oral MEK inhibitor selumetinib was the first to show clinical benefit for any systemic therapy in a randomized fashion. This increasing understanding of the biology of UM offers hope that novel treatments will continu作者: Forsake 時間: 2025-3-28 06:33 作者: fender 時間: 2025-3-28 12:15
Novel Treatments in Development for Melanoma,lso allowed for the first time a detailed understanding of an individual patient’s cancer at the genomic and proteomic level. This information is now starting to be employed at all stages of cancer treatment, including diagnosis, choice of drug therapy, treatment monitoring, and analysis of resistan作者: 強制性 時間: 2025-3-28 17:21 作者: hieroglyphic 時間: 2025-3-28 19:02 作者: Graduated 時間: 2025-3-29 02:21
Melanoma Epidemiology and Prevention,well. Sun exposure can be classified as intermittent, chronic, or cumulative (overall) exposure, and each appears to have a different effect on type of melanoma. Other environmental factors, such as chemical exposures—either through occupation, atmosphere, or food—may increase risk for melanoma, and作者: Oration 時間: 2025-3-29 05:17 作者: MERIT 時間: 2025-3-29 08:39
Melanoma: Clinical Presentations,on the skin. However, melanoma can also arise on mucosal surfaces such as the oral cavity, the upper gastrointestinal mucosa, the genital mucosa, as well as the uveal tract of the eye and leptomeninges. Melanomas tend to be pigmented but can also present as pink or red lesions. They can mimic benign作者: Infantry 時間: 2025-3-29 14:10
Principles of Melanoma Staging,system is a relatively modern concept. Overall, the goals of cancer staging are to characterize the status of cancer at a specific moment in time, risk stratify, facilitate prognostication, and inform clinical decision making. The revisions to the American Joint Committee on Cancer (AJCC) melanoma s作者: 傻瓜 時間: 2025-3-29 16:12 作者: contrast-medium 時間: 2025-3-29 23:25
Adjuvant Therapy of Melanoma, melanoma tumorigenesis have established roles for inhibitors of the MAPK pathway and regulatory immune checkpoints CTLA-4 and PD-1/PD-L1. However, the majority of patients continue to present with non-metastatic disease—typically managed with surgical resection and adjuvant therapy. High-dose IFN-α作者: 連接 時間: 2025-3-30 00:20 作者: 碳水化合物 時間: 2025-3-30 05:58
Checkpoint Blockade for the Treatment of Advanced Melanoma,nt inhibition has been most extensively studied in patients with advanced melanoma and there are three FDA approved antibodies already widely used in clinical practice (ipilimumab, nivolumab, and pembrolizumab). In this chapter, we review the mechanistic basis behind the development of immune checkp作者: Crater 時間: 2025-3-30 10:50 作者: 創(chuàng)造性 時間: 2025-3-30 15:41 作者: angiography 時間: 2025-3-30 17:45
Treatment of Uveal Melanoma,lop metastases, most commonly involving the liver. Historically, prognosis for these patients has been poor, with death occurring 6–12?months from the time of metastases. Multiple trials of cytotoxic treatments largely extrapolated from cutaneous melanoma have been ineffective in metastatic UM. Tria作者: arthrodesis 時間: 2025-3-31 00:41
Mucosal Melanoma: Epidemiology, Biology and Treatment,ites of origin include the head and neck, anorectum and vulvovaginal regions. It is uniquely different from cutaneous melanoma with respect to epidemiology, etiology, pathogenesis and prognosis. The etiology and pathogenesis remain unclear. Unlike cutaneous melanoma, exposure to UV light is not an a作者: 中世紀(jì) 時間: 2025-3-31 03:10 作者: 彩色的蠟筆 時間: 2025-3-31 08:41
Pediatric Melanoma and Atypical Melanocytic Neoplasms,E criteria common to adult melanoma cases. Moreover, many melanocytic neoplasms in childhood pose diagnostic challenges to the pathologist, and sometimes cannot be unequivocally classified as benign nevi or melanoma. This chapter addresses the evaluation and management of pediatric patients with mel
